Muscle Pharm Corporation (MSLPQ)

[TheExpertHimself]

In 2014, Musclepharm expanded quite inexpensively.

Had management not diluted the stock so heavily, we would have been in a better place though...but still, 2.5 million shares (including Biozone asset purchase that ended up cheap) and a loss of $10 million from liquidity (cash and credit line) ....Musclepharm added $67 million in revenue.

Not bad at all, even if it added staff and endorsement payments it will have to pay to going forward.

So, if Q4 was an isolated debacle, and Musclepharm little by little can have the revenue climb back up while the relationship to bodybuilding.com strengthens and the protein bar category takes off....then there is hope for a little better performance of stock price....possibly getting back to $14.